Which hedge funds own CTMX? CYTOMX THERAPEUTICS INC., Q2 2026 13F holders
38 tracked hedge funds disclosed a position in CTMX (CYTOMX THERAPEUTICS INC.) in their Q2 2026 13F filings, worth $314.3m in total. The largest holder by portfolio weight is Kynam Capital Management, LP at 4.5% of its book. 7 opened a new position this quarter: Twinbeech Capital LP, Tudor Investment Corp ET AL, DLD Asset Management, LP, Walleye Capital LLC. 20 exited: Cannon Global Investment Management, LLC, Scientech Research LLC, Seven Grand Managers, LLC.
- 38
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 7
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 20
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $6.1m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $18.9m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $314m
- Combined value Sum of the holders' reported positions in the security.
- 3.1%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Cannon Global Investment Management, LLC | 1.1% | $452k |
| Scientech Research LLC | 0.9% | $1.1m |
| Seven Grand Managers, LLC | 0.1% | $1.5m |
| Diametric Capital, LP | 0.07% | $270k |
| Soleus Capital Management, L.P. | 0.06% | $1.4m |
| Burkehill Global Management, LP | 0.05% | $1.1m |
| Prelude Capital Management, LLC | 0.04% | $573k |
| Centiva Capital, LP | 0.04% | $940k |
| Catalyst Funds Management Pty Ltd | 0.04% | $243k |
| Trexquant Investment LP | 0.03% | $4.2m |
| Fox Run Management, L.L.C. | 0.03% | $150k |
| Y-Intercept (Hong Kong) Ltd | 0.01% | $787k |
| Brevan Howard Capital Management LP | 0.01% | $1.3m |
| Mangrove Partners IM, LLC | 0.01% | $123k |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 0.01% | $51.7k |
| Balyasny Asset Management L.P. | 0.01% | $3.4m |
| Jain Global LLC | 0.01% | $492k |
| Gsa Capital Partners LLP | 0.01% | $90.0k |
| Schonfeld Strategic Advisors LLC | 0.0% | $318k |
| Hudson Bay Capital Management LP | 0.0% | $379k |
Ownership over time
Who discovered CTMX first? Beta
The run: Q1 2025 → Q1 2026, +639%
| Prosight Management, LP | Q4 2024 | 0.8% | +2.4 pts |
| Venrock Adviser, LLC | Q2 2025 | – | +1.9 pts |
| Commodore Capital LP | Q2 2025 | – | +0.9 pts |
| ADAR1 Capital Management, LLC | Q2 2025 | 0.01% | +0.8 pts |
| Fairmount Funds Management LLC | Q2 2025 | – | – |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.